Seattle Genetics adds to senior management team
This article was originally published in Scrip
Executive Summary
Seattle Genetics (US) has appointed Dr Elaine Waller senior vice-president of regulatory affairs and Christopher Pawlowicz senior vice-president of human resources. Dr Waller was previously with Sonus Pharmaceuticals, where she served as senior vice-president of regulatory affairs/quality assurance and clinical research, until its merger with OncoGenex Pharmaceuticals in August. Mr Pawlowicz was previously senior vice-president of human resources and administration at MedPointe Pharmaceuticals. Seattle Genetics has also promoted Dr Jonathan Drachman from senior medical director to vice-president of early clinical development.
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.